Question 1

BSX vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Boston Scientific Corporation (BSX) scores 8.7/10 versus Merck & Company, Inc. (MRK) at 6.7/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: BSX or MRK?

Accepted Answer

Boston Scientific Corporation (BSX) scores higher on Growth (8.8/10 vs 6.2/10). Boston Scientific Corporation reports revenue growth (11.6% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is BSX or MRK more attractively valued?

Accepted Answer

Boston Scientific Corporation (BSX) scores higher on Value (9.1/10 vs 7.2/10). BSX trades at 15.0× P/E versus MRK at 11.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about BSX vs MRK?

Accepted Answer

There are 32 analysts covering BSX with a consensus price target of $85.19, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: BSX or MRK?

Accepted Answer

Boston Scientific Corporation (BSX) scores higher on Quality (7.7/10 vs 6.2/10). Net profit margin: BSX at 17.3%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: BSX or MRK?

Accepted Answer

Boston Scientific Corporation (BSX) scores higher on Financial Health (9.1/10 vs 7/10). Market beta: BSX at 0.78, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of BSX and MRK?

Accepted Answer

Boston Scientific Corporation (BSX) has a market capitalisation of $84.0B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do BSX or MRK pay dividends?

Accepted Answer

BSX does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Boston Scientific Corporation vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals